Gender effects on plasma and brain copper

Joseph Quinn, Christopher Harris, Jeffrey Kaye, Babett Lind, Raina Carter, Thimmappa Anekonda, Martina Ralle

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

The effect of gender on systemic and brain levels of copper is relatively understudied. We examined gender effects in mice and human subjects. We observed a trend to higher serum copper levels in female compared to male LaFerla triple transgenic (1399 ± 233 versus 804 ± 436 ng/mL, P = 0.06) mice, and significantly higher brain copper levels in female- versus male wild-type mice (5.2 ± 0.2 versus 4.18 ± 0.3 ng/mg wet wt, P = 0.03). Plasma copper was significantly correlated with brain copper in mice (R2=0.218; P = 0.038). Among human subjects with AD, both plasma copper (1284 ± 118 versus 853 ± 81 ng/mL, P = 0.005) and cerebrospinal fluid copper (12.8 ± 1 versus 10.4 ± 0.7 ng/mL, P = 0.01) were elevated in women compared to men. Among healthy control subjects, plasma copper (1008 ± 51 versus 836 ± 41 ng/mL; P = 0.01) was higher in women than in men, but there was no difference in cerebrospinal fluid copper. We conclude that gender differences in copper status may influence copper-mediated pathological events in the brain.

Original languageEnglish (US)
Article number150916
JournalInternational Journal of Alzheimer's Disease
DOIs
StatePublished - 2011

Fingerprint

Copper
Brain
Cerebrospinal Fluid
Healthy Volunteers
Serum

ASJC Scopus subject areas

  • Clinical Neurology
  • Behavioral Neuroscience
  • Cognitive Neuroscience
  • Aging
  • Cellular and Molecular Neuroscience
  • Neurology

Cite this

Gender effects on plasma and brain copper. / Quinn, Joseph; Harris, Christopher; Kaye, Jeffrey; Lind, Babett; Carter, Raina; Anekonda, Thimmappa; Ralle, Martina.

In: International Journal of Alzheimer's Disease, 2011.

Research output: Contribution to journalArticle

Quinn, Joseph ; Harris, Christopher ; Kaye, Jeffrey ; Lind, Babett ; Carter, Raina ; Anekonda, Thimmappa ; Ralle, Martina. / Gender effects on plasma and brain copper. In: International Journal of Alzheimer's Disease. 2011.
@article{084aa10b080c4e24a54eaedd317768b1,
title = "Gender effects on plasma and brain copper",
abstract = "The effect of gender on systemic and brain levels of copper is relatively understudied. We examined gender effects in mice and human subjects. We observed a trend to higher serum copper levels in female compared to male LaFerla triple transgenic (1399 ± 233 versus 804 ± 436 ng/mL, P = 0.06) mice, and significantly higher brain copper levels in female- versus male wild-type mice (5.2 ± 0.2 versus 4.18 ± 0.3 ng/mg wet wt, P = 0.03). Plasma copper was significantly correlated with brain copper in mice (R2=0.218; P = 0.038). Among human subjects with AD, both plasma copper (1284 ± 118 versus 853 ± 81 ng/mL, P = 0.005) and cerebrospinal fluid copper (12.8 ± 1 versus 10.4 ± 0.7 ng/mL, P = 0.01) were elevated in women compared to men. Among healthy control subjects, plasma copper (1008 ± 51 versus 836 ± 41 ng/mL; P = 0.01) was higher in women than in men, but there was no difference in cerebrospinal fluid copper. We conclude that gender differences in copper status may influence copper-mediated pathological events in the brain.",
author = "Joseph Quinn and Christopher Harris and Jeffrey Kaye and Babett Lind and Raina Carter and Thimmappa Anekonda and Martina Ralle",
year = "2011",
doi = "10.4061/2011/150916",
language = "English (US)",
journal = "International Journal of Alzheimer's Disease",
issn = "2090-8024",
publisher = "Hindawi Publishing Corporation",

}

TY - JOUR

T1 - Gender effects on plasma and brain copper

AU - Quinn, Joseph

AU - Harris, Christopher

AU - Kaye, Jeffrey

AU - Lind, Babett

AU - Carter, Raina

AU - Anekonda, Thimmappa

AU - Ralle, Martina

PY - 2011

Y1 - 2011

N2 - The effect of gender on systemic and brain levels of copper is relatively understudied. We examined gender effects in mice and human subjects. We observed a trend to higher serum copper levels in female compared to male LaFerla triple transgenic (1399 ± 233 versus 804 ± 436 ng/mL, P = 0.06) mice, and significantly higher brain copper levels in female- versus male wild-type mice (5.2 ± 0.2 versus 4.18 ± 0.3 ng/mg wet wt, P = 0.03). Plasma copper was significantly correlated with brain copper in mice (R2=0.218; P = 0.038). Among human subjects with AD, both plasma copper (1284 ± 118 versus 853 ± 81 ng/mL, P = 0.005) and cerebrospinal fluid copper (12.8 ± 1 versus 10.4 ± 0.7 ng/mL, P = 0.01) were elevated in women compared to men. Among healthy control subjects, plasma copper (1008 ± 51 versus 836 ± 41 ng/mL; P = 0.01) was higher in women than in men, but there was no difference in cerebrospinal fluid copper. We conclude that gender differences in copper status may influence copper-mediated pathological events in the brain.

AB - The effect of gender on systemic and brain levels of copper is relatively understudied. We examined gender effects in mice and human subjects. We observed a trend to higher serum copper levels in female compared to male LaFerla triple transgenic (1399 ± 233 versus 804 ± 436 ng/mL, P = 0.06) mice, and significantly higher brain copper levels in female- versus male wild-type mice (5.2 ± 0.2 versus 4.18 ± 0.3 ng/mg wet wt, P = 0.03). Plasma copper was significantly correlated with brain copper in mice (R2=0.218; P = 0.038). Among human subjects with AD, both plasma copper (1284 ± 118 versus 853 ± 81 ng/mL, P = 0.005) and cerebrospinal fluid copper (12.8 ± 1 versus 10.4 ± 0.7 ng/mL, P = 0.01) were elevated in women compared to men. Among healthy control subjects, plasma copper (1008 ± 51 versus 836 ± 41 ng/mL; P = 0.01) was higher in women than in men, but there was no difference in cerebrospinal fluid copper. We conclude that gender differences in copper status may influence copper-mediated pathological events in the brain.

UR - http://www.scopus.com/inward/record.url?scp=84855274254&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84855274254&partnerID=8YFLogxK

U2 - 10.4061/2011/150916

DO - 10.4061/2011/150916

M3 - Article

JO - International Journal of Alzheimer's Disease

JF - International Journal of Alzheimer's Disease

SN - 2090-8024

M1 - 150916

ER -